What is hydroxychloroquine & what is its use?
Chloroquine (marketed under the name Nivaquine) is an old drug used for 70 years. This medication is mainly used “in the preventive treatment and the curative treatment of malaria”. hydroxychloroquine especially prescribed for the treatment of rheumatoid arthritis or lupus.
What are the side effects of hydroxychloroquine?
Doctors warn of the risk of self-medication linked to these ads, recalling the undesirable effects of the molecule. “You have to be more alert because chloroquine has a number of undesirable effects, affections of the immunity system, gastrointestinal ailments, vomiting, liver scramble”.
coronavirus can be prevented By hydroxychloroquine?
Many Doctors have to come against the research and also the scientific journal (Mediteranee Infection) on which it was published, for the small number of patients involved, the execution not based on scientific evidence, and the fact that the vast majority of patients had symptoms very slight. Moreover, COVID-19 spontaneously heals almost all patients.
To make the situation even more intricate, the results of another study conducted by scientists from the Department of Infectious Diseases at the Saint Louis Hospital in Paris, who observed no benefit in a dozen patients treated with hydroxychloroquine and azithromycin.
In this case, the participants presented symptoms more serious than those involved in the other transalpine research (one died, two were hospitalized in intensive care and one was excluded for complications), but they are still too few to draw definitive conclusions.
How much does it cost?
One of the advantages of this molecule is that it is inexpensive, the molecule having fallen into the public domain. In public medicines, 10 packs of 10 Nivaquine tablets would cost 5.57 euros or around 5 cents per tablet. Count 5.19 euros for a box of Plaquenil.
A Chinese study was published on February 19. It concerns a clinical trial conducted in ten Chinese hospitals to measure “the effectiveness of chloroquine on the treatment of pneumonia associated with Covid-19”. It has given encouraging results with trials on “more than 100 patients” without the details of the patient profile being known.